Grimm F, Iwata Y, Sirenko O, Bittner M, Rusyn I. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes. Assay Drug Dev Technol. 2015;13:529-46 pubmed publisher

Pothoven K, Norton J, Hulse K, Suh L, Carter R, Rocci E, et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J Allergy Clin Immunol. 2015;136:737-746.e4 pubmed publisher

Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, et al. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling. Cancer Res. 2014;74:6806-19 pubmed publisher

Lauber S, Wong S, Cutz J, Tanaka M, Barra N, Lhotak S, et al. Novel function of Oncostatin M as a potent tumour-promoting agent in lung. Int J Cancer. 2015;136:831-43 pubmed publisher

Aranda A, Bezunartea J, Casales E, Rodriguez Madoz J, Larrea E, Prieto J, et al. A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system. Cell Mol Life Sci. 2014;71:4637-51 pubmed publisher

Proctor C, MacDonald C, Milner J, Rowan A, Cawston T. A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown. Arthritis Rheumatol. 2014;66:979-89 pubmed publisher

Karakawa M, Komine M, Hanakawa Y, Tsuda H, Sayama K, Tamaki K, et al. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes. J Cell Physiol. 2014;229:1935-45 pubmed publisher

Szibor M, Pöling J, Warnecke H, Kubin T, Braun T. Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration. Cell Mol Life Sci. 2014;71:1907-16 pubmed publisher

Stobbe Maicherski N, Wolff S, Wolff C, Abel J, Sydlik U, Frauenstein K, et al. The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells. FEBS J. 2013;280:6681-90 pubmed publisher

Wang Y, van Boxel Dezaire A, Cheon H, Yang J, Stark G. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proc Natl Acad Sci U S A. 2013;110:16975-80 pubmed publisher

Migita K, Izumi Y, Torigoshi T, Satomura K, Izumi M, Nishino Y, et al. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds. Clin Exp Immunol. 2013;174:356-63 pubmed publisher

Rinaldi A, Mensah A, Kwee I, Forconi F, Orlandi E, Lucioni M, et al. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma. Br J Haematol. 2013;163:194-204 pubmed publisher

Sörensen Zender I, Rong S, Susnik N, Lange J, Gueler F, Degen J, et al. Role of fibrinogen in acute ischemic kidney injury. Am J Physiol Renal Physiol. 2013;305:F777-85 pubmed publisher

Guo L, Chen C, Shi M, Wang F, Chen X, Diao D, et al. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene. 2013;32:5272-82 pubmed publisher

Giot J, Paris I, Levillain P, Huguier V, Charreau S, Delwail A, et al. Involvement of IL-1 and oncostatin M in acanthosis associated with hypertensive leg ulcer. Am J Pathol. 2013;182:806-18 pubmed publisher

Liang H, Block T, Wang M, Nefsky B, Long R, Hafner J, et al. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark. 2012;11:161-71 pubmed publisher

Wang M, Pan C, Chiou S, Chen W, Chang H, Lee O, et al. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res. 2012;72:6051-64 pubmed publisher

Canady J, Arndt S, Karrer S, Bosserhoff A. Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol. 2013;133:647-657 pubmed publisher

Albasanz Puig A, Murray J, Namekata M, Wijelath E. Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem Biophys Res Commun. 2012;428:179-84 pubmed publisher

Tu H, Lin T, Chiu Y, Tang C, Yang R, Fu W. Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. J Cell Physiol. 2013;228:983-90 pubmed publisher

Sone M, Nishikawa Y, Nagahama Y, Kumagai E, Doi Y, Omori Y, et al. Recovery of mature hepatocytic phenotype following bile ductular transdifferentiation of rat hepatocytes in vitro. Am J Pathol. 2012;181:2094-104 pubmed publisher

David E, Tirode F, Baud huin M, Guihard P, Laud K, Delattre O, et al. Oncostatin M is a growth factor for Ewing sarcoma. Am J Pathol. 2012;181:1782-95 pubmed publisher

Ko H, Kang H, Kim H, Choi S, Park I, Shin J. The effects of oncostatin M on trophoblast cells: influence on matrix metalloproteinases-2 and -9, and invasion activity. Placenta. 2012;33:908-13 pubmed publisher

Ganesh K, Das A, Dickerson R, Khanna S, Parinandi N, Gordillo G, et al. Prostaglandin E? induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway. J Immunol. 2012;189:2563-73 pubmed publisher

Chollangi S, Mather T, Rodgers K, Ash J. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor. J Biol Chem. 2012;287:32848-59 pubmed

Sarközi R, Flucher K, Haller V, Pirklbauer M, Mayer G, Schramek H. Oncostatin M inhibits TGF-?1-induced CTGF expression via STAT3 in human proximal tubular cells. Biochem Biophys Res Commun. 2012;424:801-6 pubmed publisher

Nicolaidou V, Wong M, Redpath A, Ersek A, Baban D, Williams L, et al. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS ONE. 2012;7:e39871 pubmed publisher

Kanda N, Hau C, Tada Y, Sato S, Watanabe S. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M. Allergy. 2012;67:804-12 pubmed publisher

Ishkitiev N, Yaegaki K, Imai T, Tanaka T, Nakahara T, Ishikawa H, et al. High-purity hepatic lineage differentiated from dental pulp stem cells in serum-free medium. J Endod. 2012;38:475-80 pubmed publisher

Pechkovsky D, Prele C, Wong J, Hogaboam C, McAnulty R, Laurent G, et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Am J Pathol. 2012;180:1398-412 pubmed publisher

Gilbert S, Blain E, al Sabah A, Zhang Y, Duance V, Mason D. Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes. Eur Cell Mater. 2012;23:41-57 pubmed

West N, Murphy L, Watson P. Oncostatin M suppresses oestrogen receptor-? expression and is associated with poor outcome in human breast cancer. Endocr Relat Cancer. 2012;19:181-95 pubmed publisher

Guihard P, Danger Y, Brounais B, David E, Brion R, Delecrin J, et al. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells. 2012;30:762-72 pubmed publisher

Pöling J, Gajawada P, Lörchner H, Polyakova V, Szibor M, Böttger T, et al. The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease. Cell Cycle. 2012;11:439-45 pubmed publisher

Becerik S, Oztürk V, Atmaca H, Atilla G, Emingil G. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J Periodontol. 2012;83:1304-13 pubmed

Langeslag M, Constantin C, Andratsch M, Quarta S, Mair N, Kress M. Oncostatin M induces heat hypersensitivity by gp130-dependent sensitization of TRPV1 in sensory neurons. Mol Pain. 2011;7:102 pubmed publisher

Kanda N, Watanabe S. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M. Immunobiology. 2012;217:436-45 pubmed publisher

Chen Y, Tseng C, Wang H, Kuo H, Yang V, Lee O. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology. 2012;55:1193-203 pubmed publisher

Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, et al. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011;9:420-32 pubmed publisher

Inada M, Follenzi A, Cheng K, Surana M, Joseph B, Benten D, et al. Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation. J Cell Sci. 2008;121:1002-13 pubmed publisher

Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989;140:323-34 pubmed